Member Info for ratcliffewriter

'This fundraising is intended to support in-licensing activities, intellectual property expansion, preclinical development, and the growth of ValiRx Animal Health.'

The placing will more or less cover day to day running costs and not a lot else.

Well done Porky - you called it right yet again.

Does anyone take Zak Mir's stuff seriously? It seems to be (sensibly) bulging with caveats before it starts, and covered in terms like 'we expect' (the Royal 'we' is it?), loads of guff about 'trend channels', '50 day' things and 'rug pulling' - sounds like a peasant tugging a forelock more than investment suggestions.

Of particular note is that he 'tipped' Scancell the other day with a price target of around 18p - it sailed through that almost as if he had absolutely no idea what was going to happen to the share price in real life. There was a little pause around 18p as the followers of the self fulfilling prophesy got out on their 'leader's' suggestion (or guess), but then ploughed satisfyingly upwards. So today, guess what? - another tip, pointing at the high 20s with the wonderful words 'Good to see that Scancell is responding to the charting' - a real bit of comedy gold, but tempered by a dose of truth when followed by the words '...or responding to people buying shares...'

Exactly.

A little more research and a bit less what looks like self promotion might make for more credibility. I wonder what the comments will be if there is no news for a while and the share price stagnates or declines for a bit, or if there is more good news and it soars? Presumably it will all have been predictable with a bit of diligent chart work....my backside.

Ok Notpotalot, so what you're saying is you are underwater and have been for the last 6 months, and now heading for a placing. Much clearer when it's phrased like that.

The bid is currently below the price of the last placing - what might the next one be priced at? 0.2 looks pretty unlikely now, and I presume it isn't allowed ot be below the nominal value of the shares. Maybe paternostpauper can give us his thoughts as what looks to be a critical point looms larger.

the real canny ones don't hop from share to share giving trading advice and boasting or regaling others with tales of their inevitable success. they keep things to themselves and get on with making money. charts are ofncourse an excellent way of sounding like a soothsayer with an excuse for every incorrect prediction. get enough people to listen and it can become almost a self-fulfilling prophesy - 'this will rise!' - all pile in and guess what? it rises. 'this rise shows that it will reach up to 10p in the next 2 weeks.' after a bit of piling in it hits maybe 9.5p and the followers start selling and surprise surprise the 10p peak prediction comes true.

must go now - have to boil a few newts and sacrifice another black ****erel to see where it is astute to invest next week.

Almost certainly. And some blisters on the hand I imagine.

Given the lack of dreamworld posts for over well over a week, it seems that maybe the hype crew have come to their senses and stopped trying to polish a Richard the Third. Perhaps we can wait for the placing and then see where they think the company is headed, rather than having the Halelujah chorus every time an RNS comes out saying the office cleaner has won a tenner on the lottery.

Chill time, Marcus, whatever. Easily mixed up, but an interesting conjecture to think about.

This is what Marcus had to say - an interesting hypothesis and one which has crossed my mind too.

Hang in there would be my advice, something isn’t right (in a good way).

Typical AIM companies push out whatever news they can muster, Avacta is a brilliant example.

Yet here at Scancell we have been in a period of the opposite.

1. Avidimab relative silence, virtually unmentioned in news and other releases having been raved about as a separate platform prior. It’s key to Scib, Glymabs and patent creation or enhancement to any Mab

They are now proving it adds durability to tumour shrinkage.

2. The Glymab recent enhancement, we’ve had a brief mention of how fantastic the upgrade is but no inner details released…̷0; that’s nuts.

3. FDA fast track has been achieved, which is big news, but no podcast after that news.

4. Clearly more data out there, clearly shared at AACR (77% PFS) but the inner details have not been shared.

5. Eric Rubin, the key figure at Merck overseeing the development of the most successful immunotherapy treatment (keytruda) and key figure in the overseeing of the personalised vaccine, slips onto the Scancell panel unannounced.

6. Modi news phase 2’s repeatedly pushed out.

All of the above and some would have been released as news and raved about by typical AIM companies.

If Avacta had Rubin appearing on their panel, the news would have been red hot, social media going berserk (and the share price)

My personal conclusion is talks have become so serious, Scancell either have no need to say anything to catch attention or discussions have required such restrictions, or both.

This is not normal AIM company behaviour by a long way, it’s nigh on absurd. They may already have offers on the table, waiting to see if anyone involved is going to up their offer.

No other explanation seems to be worthy to explain the silence.

Durrant's Special Brew.

The most accurate interpretation of that chart tells me that tomorrow will be mainly dry with the chance of a shower, and around 16 centigrade.

Dear Simon - You may have changed name but your self control hasn't improved, nor your capacity for reading comments properly. Night night.

The comment was in relation to the integrity of certain high profile individuals, not policy. You seem to have missed the point, but never mind Simon.

Cardboard labs was definitely imaginative. My perennial favourite was Knowlesi, bless him - he bleated 'lifestyle company' whenever he could, poured unwavering scorn on the whole management team, and then after persistent and well-founded ridicule chucked his teddy out of the pram and left. The entertaining twist came when he popped up on the 'other side' relatively recently talking about the good prospects for his holdings in Scancell. He probably belongs in high level American Republican politics.

Statistically I suppose so. Anyway, if it get around 18p expect a rush of sells and then maybe normality can resume. We will probably also see a rash of new posters proclaiming great knowledge and research (good and bad) who have never appeared before and will leave after a few days. Hey ho...

A Zak Mir tip? That's usually the kiss of death then...

I'm sure paternostpauper will spend the weekend trying to convince you 'it's all very different now' and 'it isn't a loss if you don't sell', and other one-liners which aren't funny when it's your own money.

Sorry to hear you got fleeced by this crew.

Let's hope they don't have to include a massive bung to that imbecile RFK to make things smoother. I believe Sclp's science is above and beyond that sort of level.

An excellent RNS, and as an aside it does rather put to bed the 'Scancell is a leaky ship' and 'it's all a con' posts we've had here and elsewhere, not to mention the 'lifestyle company' pundits. This is serious data at the highest level. Away from the boards I'd love to be a fly on the wall in a few plush offices in the pharma industry this morning.

So basically at least two 'promising' deadlines now overdue with no news, and either dead silence or nothing moving on everything else. Just needs at least 100 percent rise to generate even a flicker of hope of warrants being taken up. And all this 'hope' in a post from a serial ramper who is presumably keen to attract novices so he can exit with less loss than he's currently sat on.